Drugs for Loiasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 16)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Diethylcarbamazine |
Approved, Investigational, Vet_approved |
Phase 4,Phase 2,Not Applicable |
|
90-89-1 |
3052
|
Synonyms:
12672-34-3
1642-54-2 (citrate (1:1))
1-Diethylcarbamyl-4-methylpiperazine
4-23-00-00225 (Beilstein Handbook Reference)
5348-97-0
5348-97-0 (mono-hydrochloride)
8028-18-0
84L
90-89-1
AB00053457
AC1L1F2E
AI3-19612
AKOS003268016
Aventis brand OF diethylcarbamazine citrate
Bitirazine
BPBio1_000208
BRD-K45542189-048-05-6
BRN 0143029
BSPBio_000188
BSPBio_002179
C07968
Camin
Camin (TN)
Caracide
Carbamazine
Carbilazine
Caricide
CHEMBL684
CID3052
Citrate, diethylcarbamazine
Cypip
D07825
DB00711
Decacide
Diaethylcarbamazinum
Diethyl carbamazine
Diethylcarbamazin
diethylcarbamazine
Diéthylcarbamazine
Diethylcarbamazine (INN)
Diethylcarbamazine [INN:BAN]
Diethylcarbamazine citrate
Diethylcarbamazine citrate (1:1)
Diethylcarbamazine citrate (1:2)
Diethylcarbamazine L-tartrate (1:1)
Diethylcarbamazine maleate
Diethylcarbamazine monohydrochloride
|
Diethylcarbamazine phosphate (1:1)
Diethylcarbamazinum
Diethylcarbamazinum [INN-Latin]
Dietilcarbamazina
Dietilcarbamazina [INN-Spanish]
Ditrazine base
Ditrazine Base
DivK1c_000548
EINECS 202-023-3
Ethodryl
FR-1031
Hetrazan
IDI1_000548
KBio1_000548
KBio2_001418
KBio2_003986
KBio2_006554
KBio3_001399
KBioGR_001081
KBioSS_001418
Loxuran
LS-110688
Luxuran
Maleate, diethylcarbamazine
MolPort-001-788-448
Monohydrochloride, diethylcarbamazine
N,N-Diethyl-4-methyl-1-piperazinecarboxamide
N,N-diethyl-4-methylpiperazine-1-carboxamide
NCGC00178778-01
NCGC00178778-02
NINDS_000548
Notezine
NSC1364
Prestwick0_000284
Prestwick1_000284
Prestwick2_000284
Prestwick3_000284
Spatonin
SPBio_001203
SPBio_002407
Spectrum_000938
Spectrum2_001022
Spectrum3_000390
Spectrum4_000511
Spectrum5_000877
UNII-V867Q8X3ZD
|
|
2 |
|
Ivermectin |
Approved, Investigational, Vet_approved |
Phase 4,Not Applicable |
|
70288-86-7 |
6474909
|
Synonyms:
(2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-20,20b-dihydroxy-5',6,8,19-tetramethyl-6'-[(1S)-1-methylpropyl]-17-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyranoside
71827-03-7
AB00513813
AC1MJ4GR
AC1N7O27
BPBio1_000322
BRD-K24652731-001-02-7
BSPBio_000292
CHEMBL341047
CID11957587
CID4330618
CID6321424
CID6419971
CID6427057
EU-0100693
FT-0082656
HMS1568O14
HMS2089M09
I 8898
I8898_SIGMA
|
Ivermectin
IVERMECTIN
Ivermectina
Ivermectine
Ivermectinum
Lopac0_000693
MK-933
MLS001333247
MLS001333248
MLS002153248
MolPort-006-394-715
NCGC00094047-01
NCGC00094047-02
NCGC00094047-03
Prestwick_516
Prestwick2_000156
Prestwick3_000156
S1351_Selleck
SMR000857211
|
|
3 |
|
Lipoxygenase Inhibitors |
|
Phase 4,Phase 2,Not Applicable |
|
|
|
4 |
|
Anti-Infective Agents |
|
Phase 4,Phase 2,Not Applicable |
|
|
|
5 |
|
Antiparasitic Agents |
|
Phase 4,Phase 2,Not Applicable |
|
|
|
6 |
|
Anthelmintics |
|
Phase 4,Phase 2,Not Applicable |
|
|
|
7 |
|
Reslizumab |
Approved, Investigational |
Phase 2 |
|
|
|
8 |
|
Anti-Asthmatic Agents |
|
Phase 2 |
|
|
|
9 |
|
Antibodies, Monoclonal |
|
Phase 2 |
|
|
|
10 |
|
Antibodies |
|
Phase 2 |
|
|
|
11 |
|
Respiratory System Agents |
|
Phase 2 |
|
|
|
12 |
|
Immunoglobulins |
|
Phase 2 |
|
|
|
13 |
|
Albendazole |
Approved, Vet_approved |
Not Applicable |
|
54965-21-8 |
2082
|
Synonyms:
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle [French]
(5-(propylthio)-1H-Benzimidazol-2-yl)carbamate methyl ester
(5-(propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester
(5-(propylthio)-1H-Benzimidazol-2-yl)carbamic acid methyl ester
(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester
(5-Propylsulfanyl-1H-benzoimidazol-2-yl)-carbamic acid methyl ester
[5-(Propylthio)benzimidazol-2-yl]carbamic Acid Methyl Ester
[5-(Propythio)-1H-benzimidazol-2-yl]carbamic acid methyl ester
5-(propylthio)-2-carbomethoxyaminobenzimidazole
5-(propylthio)-2-Carbomethoxyaminobenzimidazole
5-(Propylthio)-2-carbomethoxyaminobenzimidazole
54965-21-8
A4673_FLUKA
A4673_SIGMA
AB00052377
AC-015
AC1L1CVL
AC1Q2YKD
AKOS000540882
Albendazol
Albendazol [INN-Spanish]
albendazole
Albendazole
Albendazole (JAN/USP/INN)
Albendazole [USAN:INN:BAN:JAN]
Albendazole armstrong brand
Albendazole Armstrong Brand
Albendazole diba brand
Albendazole Diba Brand
Albendazole fustery brand
Albendazole Fustery Brand
Albendazole hormona brand
Albendazole Hormona Brand
Albendazole liferpal brand
Albendazole Liferpal Brand
Albendazole monohydrochloride
Albendazole Monohydrochloride
Albendazole Noe-Socopharm Brand
Albendazole noé-socopharm brand
Albendazole pfizer brand
Albendazole Pfizer Brand
Albendazole sanicoopa brand
Albendazole Sanicoopa Brand
Albendazole valdecasas brand
Albendazole Valdecasas Brand
Albendazolum
Albendazolum [INN-Latin]
Albendoral
Albenza
Albenza (TN)
Albenza, Eskazole, Zentel, Andazol, Albendazole
Armstrong brand OF albendazole
Armstrong Brand of Albendazole
BAS 00439961
BB_SC-1386
Bendapar
BIDD:GT0615
Bilutac
BIM-0051849.0001
BPBio1_000038
BRD-K79131256-001-04-7
BSPBio_000034
BSPBio_002548
C01779
CARBAMIC ACID, (5-(PROPYLTHIO)-1H-BENZIMIDAZOL-2-YL)-, METHYL ESTER
Carbamic acid, [5-(propylthio)-1H-benzimidazol-2-yl]-, methyl ester
CAS-54965-21-8
CHEBI:16664
CHEBI:506787
CHEMBL1483
ChemDiv1_000190
ChemDivAM_000003
CID2082
CPD000036735
D00134
D015766
DB00518
Diba brand OF albendazole
Diba Brand of Albendazole
Digezanol
Disthelm
Disthelm, mediamix V
Disthelm, Mediamix V
DivK1c_000704
EINECS 259-414-7
Endoplus
Eskazole
Fustery brand OF albendazole
Fustery Brand of Albendazole
Gascop
HMS1568B16
HMS1922K04
HMS2090G19
HMS2093K13
HMS502D06
HMS587I14
Hormona brand OF albendazole
|
Hormona Brand of Albendazole
HSDB 7444
I01-0380
IDI1_000704
InChI=1/C12H15N3O2S/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)
KBio1_000704
KBio2_002012
KBio2_004580
KBio2_007148
KBioGR_000801
KBioSS_002012
Liferpal brand OF albendazole
Liferpal Brand of Albendazole
LS-50618
Lurdex
Mediamix V disthelm
Mediamix V Disthelm
methyl [(2Z)-5-(propylsulfanyl)-1,3-dihydro-2H-benzimidazol-2-ylidene]carbamate
methyl [5-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
methyl [5-(propylthio)-1H-benzimidazol-2-yl]carbamate
Methyl [5-(Propylthio)benzimidazol-2-yl]carbamate
methyl [6-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
Methyl 5-(propylthio)-2-benzimidazolecarbamate
Methyl 5-(propyl-thio)-2-benzimidazolecarbamate
methyl N-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate
methyl N-[6-(propylsulfanyl)-1H-1,3-benzodiazol-2-yl]carbamate
Methyl-5-[propylthio]-2-benzimidazole carbamate
Metiazol
MLS000069722
MolPort-000-726-929
MolPort-000-760-571
MolPort-001-932-918
Monohydrochloride, albendazole
Monohydrochloride, Albendazole
NCGC00016876-01
NCGC00016876-02
NCGC00022896-03
NCGC00022896-04
NCGC00022896-05
NCGC00022896-06
NCGC00022896-07
NINDS_000704
Noe Socopharm Brand of Albendazole
Noé socopharm brand OF albendazole
Noe-Socopharm Brand of Albendazole
Noé-socopharm brand OF albendazole
NSC 220008
NSC220008
O-methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate
O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate
O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamic acid
Oprea1_429292
Oprea1_585016
Oprea1_640007
Pfizer brand OF albendazole
Pfizer Brand of Albendazole
Prestwick_675
Prestwick0_000247
Prestwick1_000247
Prestwick2_000247
Prestwick3_000247
Proftril
S1640_Selleck
SAM002589939
Sanicoopa brand OF albendazole
Sanicoopa Brand of Albendazole
SK And F 62979
SK And F62979
SK And F-62979
SK&F 62979
SK&F62979
SK&F-62979
SKF 62979
SKF62979
SKF-62979
Smith Kline & French Brand of Albendazole
SmithKline beecham brand OF albendazole
SmithKline Beecham Brand of Albendazole
SMR000036735
SPBio_002253
Spectrum_001532
SPECTRUM1503903
Spectrum4_000201
Spectrum5_001567
STK387550
STL046130
STOCK2S-67946
TL8003543
UNII-F4216019LN
V Disthelm, mediamix
V Disthelm, Mediamix
Valbazen
Valdecasas brand OF albendazole
Valdecasas Brand of Albendazole
VU0239747-6
Zental
Zentel
ZINC17146904
|
|
14 |
|
Suramin |
Investigational |
|
|
145-63-1 |
5361
|
Synonyms:
1,3,5-Naphthalenetrisulfonic acid, 8,8'-[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis- (9CI)
1,3,5-Naphthalenetrisulfonic acid, 8,8'-[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-, hexasodium salt
1,3,5-Naphthalenetrisulfonic acid, 8,8'-[ureylenebis[m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino]]di- (8CI)
1,3,5-Naphthalenetrisulfonic acid, 8,8'-[ureylenebis[m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino]]di-, hexasodium salt
129-46-4 (hexa-hydrochloride salt)
145-63-1
3-14-00-02267 (Beilstein Handbook Reference)
8,8'-(Carbonylbis(imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino))bisnaphthalene-1,3,5-trisulphonic acid
8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonate
8,8'-[CARBONYLBIS[IMINO-3,1-PHENYLENECARBONYLIMINO(4-METHYL-3,1-PHENYLENE)CARBONYLIMINO]]BIS-1,3,5-NAPHTHALENETRISULFONIC
8,8'-[Carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonyl-imino]]bis-1,3,5-naphthalenetrisulfonic acid
8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid
8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonIC ACID
8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulphonate
8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulphonic acid
8,8'-[Carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonyl-imino]]bis-1,3,5-napthalenetrisulfonic acid
8,8'-[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bisnaphthalene-1,3,5-trisulphonic acid
8,8'-[Ureylenebis[m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino]]di-1,3,5-naphthalenetrisulfonic acid
8-[[4-methyl-3-[[3-[[3-[[2-methyl-5-[(4,6,8-trisulfonaphthalen-1-yl)carbamoyl]phenyl]carbamoyl]phenyl]carbamoylamino]benzoyl]amino]benzoyl]amino]naphthalene-1,3,5-trisulfonic acid
AC1L1K6K
Antrypol
Bayer 205
Belganyl
BRN 3230873
BSPBio_002248
C07974
C51H40N6O23S6
CHEBI:45906
CHEMBL265502
CID5361
DB04786
DivK1c_006758
EINECS 205-658-4
Farma
Farma 939
Fourneau
Germanin
Harnstoff, symmetischer der 3-aminobenzoyl-3-amino-4-methylbenzoyl-1-naphthylamin-4,6,8-trisulfonsaeure
Hexasodium salt suramin
KBio1_001702
KBio2_002397
|
KBio2_004965
KBio2_007533
KBio3_001468
KBioGR_001774
KBioSS_002402
L000585
Lopac0_001182
LS-95867
m,m'-Ureylen-bis-(8-(m-(benzamido)-p-toluamido)naphthalin-1,3,5-trisulfonsaeure)
Monosodium salt suramin
Moranil
Moranyl
Naganil
Naganin
Naganine
Naganol
Naganol 6 Na
Naphuride
NCGC00163318-01
NSC 34936
NSC34936
Salt suramin, hexasodium
Salt suramin, monosodium
SGCTO-001
Sodium suramin
Sodium, suramin
SpecPlus_000662
Spectrum_001877
Spectrum3_000724
Spectrum4_001247
suramin
Suramin
Suramin sodium
SURAMIN SODIUM
Suramin, hexasodium salt
Suramin, monosodium salt
Suramine
Suramine sodium
SVR
sym-bis(m-aminobenzoyl-m-amino-p-methylbenzoyl-1-napthylamino-4,6,8-trisulfonate) carbamide
WLN: L66J BSWQ DSWQ GSWQ JMVR D1 CMVR CMVMR CVMR B1 EVM-JL66J BSWQ DSWQ GSWQ &-NA-6
|
|
15 |
|
Antiprotozoal Agents |
|
Not Applicable |
|
|
|
16 |
|
Antimitotic Agents |
|
Not Applicable |
|
|
|
Interventional clinical trials:
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Post-treatment Effects of Ivermectin (IVM) or Diethylcarbamazine (DEC) in Loiasis |
Completed |
NCT01593722
|
Phase 4 |
Diethylcarbamazine;Ivermectin |
2 |
Reslizumab to Prevent Post-treatment Eosinophilia in Loiasis |
Completed |
NCT01111305
|
Phase 2 |
Reslizumab;Diethylcarbamazine |
3 |
Impact of Educational and Professional Supportive Interventions on Nursing Home Quality Indicators |
Completed |
NCT01703689
|
Not Applicable |
|
4 |
Host Response to Infection and Treatment in Filarial Diseases |
Recruiting |
NCT00001230
|
|
|
5 |
Lymphatic Filariasis (LF) in Ivory Coast |
Active, not recruiting |
NCT02974049
|
Not Applicable |
Albendazole;Ivermectin;Diethylcarbamazine |
Cochrane evidence based reviews: loiasis
|